- Home
- Publications
- Publication Search
- Publication Details
Title
Pegaspargase: A Review in Acute Lymphoblastic Leukaemia
Authors
Keywords
-
Journal
DRUGS
Volume 79, Issue 7, Pages 767-777
Publisher
Springer Science and Business Media LLC
Online
2019-04-27
DOI
10.1007/s40265-019-01120-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403
- (2019) Wendy Stock et al. BLOOD
- Population Pharmacokinetics to Model the Time-Varying Clearance of the PEGylated Asparaginase Oncaspar® in Children with Acute Lymphoblastic Leukemia
- (2017) Gudrun Würthwein et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children’s oncology group (COG) clinical trials
- (2017) Michael J. Burke et al. LEUKEMIA & LYMPHOMA
- Efficacy and safety of native versus pegylated Escherichia coli asparaginase for treatment of adults with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemia
- (2017) Josep-Maria Ribera et al. LEUKEMIA & LYMPHOMA
- The Cost-Effectiveness of Pegaspargase for First-Line Treatment of Acute Lymphoblastic Leukaemia: A Cost-Utility Analysis
- (2017) S Basu et al. VALUE IN HEALTH
- Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-Münster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen
- (2016) Michael E. Rytting et al. AMERICAN JOURNAL OF HEMATOLOGY
- Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation
- (2016) I. M. van der Sluis et al. HAEMATOLOGICA
- Allergic Reactions With Intravenous Compared With Intramuscular Pegaspargase in Children With High-risk Acute Lymphoblastic Leukemia
- (2016) Tamara MacDonald et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Comparison of hypersensitivity rates to intravenous and intramuscular PEG-asparaginase in children with acute lymphoblastic leukemia: A meta-analysis and systematic review
- (2016) Haroon Hasan et al. PEDIATRIC BLOOD & CANCER
- Pharmacoeconomic Assessment Of Pegaspargase Versus Asparaginase in Acute Lymphocytic Leukemia
- (2016) R Villoro et al. VALUE IN HEALTH
- Pegaspargase In The Treatment of Acute Lymphoblastic Leukemia: A CMA Model Demonstrates Its Economic Benefit For The Italian National Health System
- (2016) M Faiella et al. VALUE IN HEALTH
- Cost-minimization Analysis of Pegaspargase And Native E. Coli Asparaginase To Treat Children And Adults with Acute Lymphoblastic Leukemia In Belgium
- (2016) C Delattre et al. VALUE IN HEALTH
- Pegaspargase Versus Asparaginase In Childhood Acute Lymphoblastic Leukemia: A Cost-Minimization Analysis In France
- (2016) C Lecureuil et al. VALUE IN HEALTH
- Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation
- (2016) I. M. van der Sluis et al. HAEMATOLOGICA
- Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial
- (2015) Andrew E Place et al. LANCET ONCOLOGY
- Allergic Reactions Associated with Intravenous Versus Intramuscular Pegaspargase: A Retrospective Chart Review
- (2015) Lesleigh S. Abbott et al. PEDIATRIC DRUGS
- A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia
- (2014) Wing H. Tong et al. BLOOD
- Pharmacokinetic and Pharmacodynamic Properties of Calaspargase PegolEscherichia coliL-Asparaginase in the Treatment of Patients With Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Study AALL07P4
- (2014) Anne L. Angiolillo et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacokinetics-Based Integration of Multiple Doses of Intravenous Pegaspargase in a Pediatric Regimen for Adults With Newly Diagnosed Acute Lymphoblastic Leukemia
- (2014) Dan Douer et al. JOURNAL OF CLINICAL ONCOLOGY
- Polyethylene Glycol-conjugated L-asparaginase Versus Native L-asparaginase in Combination With Standard Agents for Children With Acute Lymphoblastic Leukemia in Second Bone Marrow Relapse
- (2011) Joanne Kurtzberg et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel
- (2011) Wendy Stock et al. LEUKEMIA & LYMPHOMA
- Delivery of Therapeutic Proteins
- (2010) Dipak S. Pisal et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia
- (2009) L. B. Silverman et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started